A New Year with Familiar Viruses: Bill Morice, M.D., Ph.D. - Insights
joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to welcome the new year and discuss the increase of respiratory viruses....
Mayo Clinic researchers identify new disease subtype linked to recurrent blood clots - Insights
Mayo Clinic researchers identify a new subtype of MGTS, linked to recurrent blood clots, with significant diagnostic challenges and treatment implications....
New Blood Test to Help Determine Heart Disease Highlighted in European Heart Journal - Insights
European Heart Journal recently highlighted Mayo Clinic's new blood test that may predict cardiovascular events in patients with or without coronary artery disease....
Avian Flu Outbreaks and New COVID-19 Variants: Matthew Binnicker, Ph.D. - Insights
clinical virologist at Mayo Clinic. They discuss the widespread outbreaks of H5N1 bird flu and the new “FLiRT” variants of COVID-19....
Information: Interpreting Laboratory Tests to Determine New vs. Residual Use of Marijuana - Insights
In this month's "Hot Topic," Paul Jannetto, Ph.D., identifies how to determine new vs. residual use of marijuana in a patient, and teaches how to calculate the carboxy-tetrahydrocannabinol (carboxy-THC)...
Cytomegalovirus Antiviral Resistance Testing: A New Assay for Detection of Mutations Associated with
infections, the virus may develop resistance to the drugs. This “Hot Topic” will provide an overview of a new test developed by Mayo Clinic Laboratories, which uses next-generation sequencing technology to identify...
Fergus Couch, Ph.D., co-authors new guidelines for interpreting ATM cancer gene variants - Insights
Clinic’s Division of Experimental Pathology and Laboratory Medicine, led a team that recently published new National Institutes of Health and U.S. Food and Drug Administration-approved guidelines for the interpretation...
Leslie Donato, Ph.D., Discusses New Lab Testing Options to Evaluate IBS-D Patients - Insights
Clinical Core Laboratory at Mayo Clinic, recently authored an article in "Medical Lab Management" on new laboratory testing options to evaluate irritable bowel syndrome with diarrhea (IBS-D) patients. ...
New Panels Help Find Cause of Rapidly Progressive Dementia: Gregg Day, M.D. - Insights
(CJD). Gregory (Gregg) Day, M.D., explains how Mayo Clinic Laboratories' unique RPD evaluation and new CJD test help pinpoint diagnosis, to guide prognosis and treatment decisions....
Lyme Disease, Part 2: Borrelia mayonii-A New Cause of Lyme Disease in Upper Midwest - Insights
cause Lyme disease in Europe. We will also discuss using PCR and melting curve analysis to identify a new species of Borrelia....